DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight” report provides comprehensive insights about 80+ companies ...

CheckMate -8HW enrolled patients with colorectal cancer whose tumors were characterized as microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) unresectable or metastatic.

Upon Opdualag’s approval in 2022 as a first-in-class cancer immunotherapy, Bristol Myers Squibb was anxious to explore its potential in a variety of indications. | Bristol Myers Squibb is striking out ...

AstraZeneca and Daiichi Sankyo's HER2-directed antibody-drug conjugate Enhertu (trastuzumab deruxtecan) already has ...

Kim Newcomer, director of volunteers, Colorectal Cancer Alliance, discusses a study conducted with Takeda and the Harris Poll, focusing on the treatment experiences of patients with metastatic ...

We need a much larger study." In her introductory comments, Geng agreed with Kunz's assessment that unresectable locally advanced/metastatic G/GEJ cancer has a poor prognosis, and chemotherapy is ...

The FDA granted fast track status to IBI363 for the treatment of patients with advanced squamous lung cancer after prior ...